AR093738A1 - Formas solidas que comprenden inhibidores de ns5a de hcv, sus composiciones y sus usos - Google Patents

Formas solidas que comprenden inhibidores de ns5a de hcv, sus composiciones y sus usos

Info

Publication number
AR093738A1
AR093738A1 ARP130100443A ARP130100443A AR093738A1 AR 093738 A1 AR093738 A1 AR 093738A1 AR P130100443 A ARP130100443 A AR P130100443A AR P130100443 A ARP130100443 A AR P130100443A AR 093738 A1 AR093738 A1 AR 093738A1
Authority
AR
Argentina
Prior art keywords
compositions
solid forms
forms including
including inhibitors
ns5a hcv
Prior art date
Application number
ARP130100443A
Other languages
English (en)
Inventor
Muchnik Anna
Lorimer Keith
Li Leping
Zhong Min
Original Assignee
Presidio Pharmaceuticals Inc
Aptuit Llc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Presidio Pharmaceuticals Inc, Aptuit Llc filed Critical Presidio Pharmaceuticals Inc
Publication of AR093738A1 publication Critical patent/AR093738A1/es

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D403/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00
    • C07D403/14—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing three or more hetero rings
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A61P31/14—Antivirals for RNA viruses
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07B—GENERAL METHODS OF ORGANIC CHEMISTRY; APPARATUS THEREFOR
    • C07B2200/00—Indexing scheme relating to specific properties of organic compounds
    • C07B2200/13—Crystalline forms, e.g. polymorphs

Abstract

Reivindicación 1: Una forma sólida de un compuesto que tiene la fórmula (1) y en una forma cristalina.
ARP130100443A 2012-02-13 2013-02-13 Formas solidas que comprenden inhibidores de ns5a de hcv, sus composiciones y sus usos AR093738A1 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US201261598249P 2012-02-13 2012-02-13

Publications (1)

Publication Number Publication Date
AR093738A1 true AR093738A1 (es) 2015-06-24

Family

ID=48984669

Family Applications (1)

Application Number Title Priority Date Filing Date
ARP130100443A AR093738A1 (es) 2012-02-13 2013-02-13 Formas solidas que comprenden inhibidores de ns5a de hcv, sus composiciones y sus usos

Country Status (21)

Country Link
US (1) US20150203474A1 (es)
EP (1) EP2814322A4 (es)
JP (1) JP2015506987A (es)
KR (1) KR20140145126A (es)
CN (1) CN104219953A (es)
AR (1) AR093738A1 (es)
AU (1) AU2013221613A1 (es)
BR (1) BR112014019585A8 (es)
CA (1) CA2864342A1 (es)
CL (1) CL2014002138A1 (es)
CO (1) CO7061084A2 (es)
EA (1) EA201491442A1 (es)
HK (1) HK1204433A1 (es)
IN (1) IN2014MN01671A (es)
MX (1) MX2014009693A (es)
PE (1) PE20142462A1 (es)
PH (1) PH12014501781A1 (es)
SG (1) SG11201404754TA (es)
TW (1) TW201339153A (es)
WO (1) WO2013123092A1 (es)
ZA (1) ZA201406740B (es)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20150023913A1 (en) 2013-07-02 2015-01-22 Bristol-Myers Squibb Company Hepatitis C Virus Inhibitors
US9717712B2 (en) 2013-07-02 2017-08-01 Bristol-Myers Squibb Company Combinations comprising tricyclohexadecahexaene derivatives for use in the treatment of hepatitis C virus
CN105530933B (zh) 2013-07-17 2018-12-11 百时美施贵宝公司 用于治疗hcv的包含联苯衍生物的组合产品
TWI679203B (zh) 2014-06-11 2019-12-11 美商基利法瑪席特有限責任公司 製備抗病毒化合物之方法
ITUB20152784A1 (it) * 2015-08-03 2017-02-03 Chemelectiva S R L Processo per la sintesi di ravidasvir
WO2017023631A1 (en) 2015-08-06 2017-02-09 Bristol-Myers Squibb Company Hepatitis c virus inhibitors
CN109134439A (zh) * 2017-06-15 2019-01-04 歌礼生物科技（杭州）有限公司 丙肝治疗药物Ravidasvir的制备方法

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2006093867A1 (en) * 2005-02-28 2006-09-08 The Rockefeller University Structure of the hepatitits c virus ns5a protein
AU2009322393B2 (en) * 2008-12-03 2017-02-02 Presidio Pharmaceuticals, Inc. Inhibitors of HCV NS5A
SG174146A1 (en) * 2009-02-27 2011-10-28 Enanta Pharm Inc Hepatitis c virus inhibitors
WO2011004276A1 (en) * 2009-07-06 2011-01-13 Pfizer Limited Hepatitis c virus inhibitors
UA108211C2 (uk) * 2009-11-04 2015-04-10 Янссен Рід Айрленд Бензімідазолімідазольні похідні
US9060971B2 (en) * 2010-03-04 2015-06-23 Enanta Pharmaceuticals, Inc. Combination pharmaceutical agents as inhibitors of HCV replication
US8877707B2 (en) * 2010-05-24 2014-11-04 Presidio Pharmaceuticals, Inc. Inhibitors of HCV NS5A

Also Published As

Publication number Publication date
SG11201404754TA (en) 2014-09-26
AU2013221613A1 (en) 2014-09-04
WO2013123092A1 (en) 2013-08-22
EP2814322A4 (en) 2015-09-23
CO7061084A2 (es) 2014-09-19
ZA201406740B (en) 2016-02-24
CL2014002138A1 (es) 2014-11-28
KR20140145126A (ko) 2014-12-22
TW201339153A (zh) 2013-10-01
HK1204433A1 (en) 2015-11-20
PH12014501781A1 (en) 2014-11-10
MX2014009693A (es) 2014-09-08
BR112014019585A2 (es) 2017-06-20
US20150203474A1 (en) 2015-07-23
PE20142462A1 (es) 2015-02-01
EP2814322A1 (en) 2014-12-24
IN2014MN01671A (es) 2015-05-29
JP2015506987A (ja) 2015-03-05
EA201491442A1 (ru) 2015-01-30
CN104219953A (zh) 2014-12-17
CA2864342A1 (en) 2013-08-22
BR112014019585A8 (pt) 2017-07-11

Similar Documents

Publication Publication Date Title
CR20160419A (es) Nuevos compuestos biciclicos
CR20150462A (es) Inhibidores de erk y sus usos
AR093738A1 (es) Formas solidas que comprenden inhibidores de ns5a de hcv, sus composiciones y sus usos
CR20150436A (es) Nuevos octahidro-pirrolo[3,4-c]-pirrol y -piridina-fenilo
CR20140318A (es) Composiciones intranasales de dexmedetomidina y métodos de uso de ellas
UY34763A (es) Inhibidores de la agregación plaquetaria
UY34632A (es) Compuestos de oxazolidin- 2- ona y usos de los mismos
UY34484A (es) Benzotienilo-pirrolotriazinas disustituidas y sus usos
EA201590534A1 (ru) Новые бициклические производные
CR20180072A (es) Nuevos compuestos biciclicos como inhibidores de atx
CR20140275A (es) Triazolopiridinas sustituidas
UY34418A (es) Compuestos derivados de la piridopiracina, su preparación, composiciones que los contienen y su uso en terapia
EA201490596A1 (ru) Новые производные дигидрохинолин-2-она
UY34234A (es) Inhibidores de la replicación de los virus de la gripe
CR20130539A (es) Triazolopiridinas
CR20140468A (es) Inhibidores de diacilglicerol aciltransferasa 2
DK3003038T3 (da) 2h-1,2,3-triazolderivater som inhibitorer af fibrose
UY34008A (es) ?formas en estado sólido de inhibidor de hiv, composición farmacéutica, uso de la misma, y procesos para preparar dichas formas?.
DK3470409T3 (da) Benzotriazol-afledt Alfa- og Beta-umættet amidforbindelse anvendt som TGF-BRI-hæmmer
UY34167A (es) Pirrolotriazinas sustituidas con hidroximetilarilo y sus usos
CR20140135A (es) Nuevos derivados de aril-quinolina
WO2015077657A3 (en) Stat3 inhibitors and uses thereof
RS54488B1 (en) NALOXOL-POLYETHYLENE GLYCOL CRYSTAL CONJUGATE
CR20160070A (es) Compuestos de triazolopiridina, composiciones y métodos de uso de los mismos
CO7020909A2 (es) Compuesto tricíclicos, composiciones que los comprenden y uso de los mismos

Legal Events

Date Code Title Description
FB Suspension of granting procedure